13F Holdings
中文EN

HCA HCA Healthcare, Inc.

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 860730 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.8%
TTM net income YoY6.8%
TTM EPS YoY16.6%
Revenue 3-yr CAGR7.6%
Net income 3-yr CAGR5.8%

Margins

Gross margin—
Operating margin—
Net margin8.6%
FCF margin7.6%
EBITDA margin—

Returns

ROE—
ROA11.0%
ROIC (approx.)—
Asset turnover1.28x

Leverage & solvency

Liabilities / assets107.2%
Debt / equity—
Current ratio0.82x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.65x
Accruals ratio-7.1%
Payout ratio10.1%
Capex / revenue6.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$75.60B$70.60B$64.97B$60.23B$58.75B
SG&A expense$548.00M$421.00M$353.00M$307.00M$337.00M
Interest expense$2.25B$2.06B$1.94B$1.74B$1.57B
Pretax income$9.83B$8.52B$7.71B$8.58B$9.83B
Income tax$2.05B$1.87B$1.61B$1.75B$2.11B
Net income$6.78B$5.76B$5.24B$5.64B$6.96B
EPS (basic)28.7022.2719.2519.4321.52
EPS (diluted)28.3322.0018.9719.1521.16
Dividends declared per share2.882.642.402.241.92
Weighted avg. shares (diluted)239.50M261.81M276.41M294.67M328.75M
Balance sheet
Cash & equivalents$1.04B$1.93B$935.00M$908.00M$1.45B
Short-term investments————$103.00M
Receivables$10.87B$10.75B$9.96B$8.89B$8.10B
Inventory$1.65B$1.74B$2.02B$2.07B$1.99B
Current assets$15.78B$16.41B$14.93B$13.64B$13.54B
PP&E, net$31.14B$29.41B$27.71B$25.57B$24.06B
Total assets$60.72B$59.51B$56.21B$52.44B$50.74B
Current liabilities$16.35B$15.18B$12.65B$9.90B$9.58B
Short-term debt$4.89B$4.70B$2.42B$370.00M$237.00M
Long-term debt$41.60B$38.33B$37.17B$37.71B$34.34B
Total debt$46.49B$43.03B$39.59B$38.08B$34.58B
Total liabilities$63.49B$58.96B$55.15B$52.51B$49.25B
Shareholders' equity-$6.03B-$2.50B-$1.77B-$2.77B-$933.00M
Net debt$45.45B$41.10B$38.66B$37.18B$33.13B
Shares outstanding224.61M249.98M265.54M277.38M305.48M
Cash flow statement
Operating cash flow$12.64B$10.51B$9.43B$8.52B$8.96B
Capital expenditure$4.94B$4.88B$4.74B$4.39B$3.58B
Free cash flow$7.69B$5.64B$4.69B$4.13B$5.38B
Investing cash flow-$4.99B-$4.93B-$5.32B-$3.39B-$2.64B
Financing cash flow-$8.55B-$4.58B-$4.09B-$5.66B-$6.66B
Depreciation & amortization$3.52B$3.31B$3.08B$2.97B$2.85B
Stock-based compensation$401.00M$360.00M$262.00M$341.00M$440.00M
Dividends paid$679.00M$690.00M$661.00M$653.00M$624.00M
Share buybacks$10.07B$6.04B$3.81B$7.00B$8.21B

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.